Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of €79.6m, up +6.1% at Constant Exchange Rates
18 April 2024 - 6:00PM
Business Wire
- Growth of 1.2% at constant exchange rates for the third quarter
of FY 2023-2024
- Over 9 months, sales in France up +5.3%.
- International sales up 8.4% at constant exchange rates over 9
months
Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME
eligible), the French market leader in surgical technologies for
lower limb orthopedics, announces its consolidated sales for the
third quarter of the 2023-24 financial year.
Olivier Jallabert, Chief Executive Officer of Amplitude
Surgical, comments: "In the first 9 months of the 2023-24
financial year, Amplitude Surgical continued its growth trajectory,
posting sales growth of +6.1% at constant exchange rates compared
with the same period last year. Business grew both in France, with
an increase of +5.3%, and internationally, with growth of +8.4% at
constant exchange rates."
Consolidated sales 9 months of FY 2023-2024
Sales 9M
2023-24
31/03/2024
31/03/2023
Change at current exchange
rates
Change at constant exchange
rates
In € thousands - IFRS
Knee and hip activities
79,614
75,417
5.6%
6.1%
Total
79,614
75,417
5.6%
6.1%
Sales Q3
2023-24
31/03/2024
31/03/2023
Change at current exchange
rates
Change at constant exchange
rates
In € thousands - IFRS
Knee and hip activities
30,557
30,209
1.2%
1.2%
Total
30,557
30,209
1.2%
1.2%
In the first 9 months (July 2003 - March 2024) of the 2023-24
financial year, Amplitude Surgical sales came to €79.6 million, up
+5.6% and +6.1% at constant exchange rates.
Over the 9 months, the knees and hips business grew by +5.3% in
France, while international distributors reported +7.8% growth, and
the Group's international subsidiaries recorded +5.8% growth at
current exchange rates and +8.7% at constant exchange rates.
Third-quarter growth was limited to 1.2%, with an increase of
1.4% in France and 2.9% at constant exchange rates for the Group's
international subsidiaries, while international distributors were
down -5.7%.
Amplitude Surgical's direct sales (French market and
international subsidiaries), which account for almost 93% of total
Group sales, rose by +6.0% at constant exchange rates.
In France, which accounts for around 73% of Group sales,
Amplitude Surgical continues to enjoy a favorable sales
momentum.
For international subsidiaries, sales were up at constant
exchange rates in Belgium, Australia and Brazil, while sales in
Switzerland and South Africa were down.
Next press release:
Full-year sales 2023-24: Thursday, July 25, 2024, after
market close.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a
leading French player on the global surgical technology market for
lower-limb orthopedics. Amplitude Surgical develops and markets
high-end products for orthopedic surgery covering the main
disorders affecting the hip and knee. Amplitude Surgical develops,
in close collaboration with surgeons, numerous high value-added
innovations in order to best meet the needs of patients, surgeons
and healthcare facilities. A leading player in France, Amplitude
Surgical is developing abroad through its subsidiaries and a
network of exclusive distributors and agents distributing its
products in more than 30 countries. As of June 30, 2023, Amplitude
Surgical employed 426 people and generated sales of nearly 100.2
million euros.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240418236921/en/
Amplitude Surgical CFO Dimitri Borchtch
finances@amplitude-surgical.com +33 (0)4 75 41 87 41
NewCap Investor Relations Thomas Grojean
amplitude@newcap.eu +33 (0)1 44 71 94 94
NewCap Media Relations Nicolas Merigeau
amplitude@newcap.eu +33 (0)1 44 71 94 98
Amplitude Surgical (EU:AMPLI)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Amplitude Surgical (EU:AMPLI)
Historical Stock Chart
Von Dez 2023 bis Dez 2024